Geneva, June 22 -- International Clinical Trials Registry received information related to the study (NCT07645846) titled 'Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma' on June 9.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Sun Yat-sen University

Condition: Locally Advanced Sinonasal Carcinoma

Intervention: Drug: Neoadjuvant Chemo-Immunotherapy

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: July 31, 2026

Target Sample Size: 23

To know more, visit https://clinicaltrials.gov/study/NCT07645846

Published by HT Digital Content Servic...